Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function

被引:88
|
作者
Fung-Leung, Wai-Ping [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Dept Immunol, San Diego, CA 92121 USA
关键词
PI3K delta; Lipid kinase; Signaling; Leukocyte; Inflammation; Autoimmune disease; CELL CYTOKINE PRODUCTION; B-CELL; CUTTING EDGE; PHOSPHATIDYLINOSITOL; 3-KINASE; P110-DELTA; PI3K; P110-GAMMA; ISOFORM; ACTIVATION; MECHANISMS;
D O I
10.1016/j.cellsig.2010.10.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PI3K delta is a lipid kinase of the PI3K class IA family involved in early signaling events of leukocytes responding to a wide variety of stimuli. The leukocyte specificity of PI3K delta is defined by its expression, whereas its signaling function is via the production of phosphoinositide 3,4,5-triphosphates at the proximity of activated receptors for recruiting other signaling molecules. The importance of PI3K delta in B cell development and function is most apparent, and its role in other leukocyte cell types can be easily demonstrated as well. PI3K delta participates in the development, activation and migration of T cells and NK cells. The role of PI3K delta in myeloid cell activities, such as inflammation driven cell infiltration, neutrophil oxidative burst, immune complex mediated macrophage activation, as well as mast cell maturation and degranulation, has been well illustrated in various studies. As a result of the broad effects of PI3K delta in leukocyte functions, the disruption of PI3K delta expression or activity leads to decreased inflammatory and immune responses in vivo. The protective role of PI3K delta inactivation in animal models of arthritis, asthma or obstructive respiratory diseases has been demonstrated. These findings suggest the potential efficacy achievable with PI3K delta inhibitors in the treatment of autoimmune and respiratory diseases. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 50 条
  • [31] Roginolisib a Highly Selective Allosteric Modulator of the Phosphoinositide 3-Kinase Delta (PI3Kδ) in Patients with Refractory/Relapsed Follicular Lymphoma
    Carlo-Stella, Carmelo
    Lahn, Michael
    Hammett, Tracey
    Kaur, Paramjit
    Zorrilla, Rebeca
    Di Conza, Giusy
    van der Veen, Lars
    Pickering, Catherine
    Santoro, Armando
    [J]. BLOOD, 2023, 142
  • [32] Profiling of Phosphatidylinositol 3-Kinase (PI3K) Proteins in Insulin Signaling Pathway
    Chakraborty, Chiranjib
    Doss, C. George Priya
    Bhatia, Rahul
    Agoramoorthy, Govindasamy
    [J]. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2015, 175 (07) : 3431 - 3446
  • [33] Profiling of Phosphatidylinositol 3-Kinase (PI3K) Proteins in Insulin Signaling Pathway
    Chiranjib Chakraborty
    C. George Priya Doss
    Rahul Bhatia
    Govindasamy Agoramoorthy
    [J]. Applied Biochemistry and Biotechnology, 2015, 175 : 3431 - 3446
  • [34] Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors
    Pemberton, Nils
    Mogemark, Mickael
    Arlbrandt, Susanne
    Bold, Peter
    Cox, Rhona J.
    Gardelli, Cristina
    Holden, Neil S.
    Karabelas, Kostas
    Karlsson, Johan
    Lever, Sarah
    Li, Xueshan
    Lindrnark, Helena
    Norberg, Monica
    Perry, Matthew W. D.
    Petersen, Jens
    Blomqvist, Sandra Rodrigo
    Thomas, Matthew
    Tyrchan, Christian
    Eriksson, Annika Westin
    Zlatoidsky, Pavol
    Osterg, Linda
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) : 5435 - 5441
  • [35] Up-regulated phosphoinositide 3-kinase γ (PI3Kγ) promotes breast cancer metastasis
    Xie, Yan
    Kirui, Joseph K.
    Jiang, Haihong
    Deng, Caishu
    Tu, Yaping
    [J]. FASEB JOURNAL, 2010, 24
  • [36] Discovery of INCB098377: a potent inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ)
    Arias, Diana A.
    Douglass, Stephen
    Truong, Lisa
    Wang, Qian
    Wang, Kathy H.
    Yang, Gengjie
    Hansbury, Michael
    O'Connor, Sybil
    Bowman, Kevin
    Collins, Robert
    Stubbs, Matthew
    Hall, Leslie
    Stevens, Christina
    Maddage, Christopher
    Douty, Brent
    Covington, Maryanne
    Leffet, Lynn
    Yue, Eddy
    Combs, Andrew
    Kim, Sunkyu
    Shin, Niu
    Koblish, Holly
    Hess, Rodrigo
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [37] Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients
    Janku, Filip
    [J]. CANCER TREATMENT REVIEWS, 2017, 59 : 93 - 101
  • [38] The phosphoinositide (PI) 3-kinase family
    Foster, FM
    Traer, CJ
    Abraham, SM
    Fry, MJ
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (15) : 3037 - 3040
  • [39] Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines
    Holzhauser, Stefan
    Lukoseviciute, Monika
    Andonova, Teodora
    Ursu, Ramona G.
    Dalianis, Tina
    Wickstrom, Malin
    Kostopoulou, Ourania N.
    [J]. ANTICANCER RESEARCH, 2020, 40 (01) : 53 - 66
  • [40] The phosphoinositide 3-kinase (PI3K)/AKT signaling pathway as a therapeutic target for the treatment of human acute myeloid leukemia (AML)
    Martelli, Alberto M.
    Tabellini, Giovanna
    Bortul, Roberta
    Nyakern, Maria
    Tazzari, Pier Luigi
    Evangelisti, Camilla
    Cocco, Lucio
    [J]. CURRENT SIGNAL TRANSDUCTION THERAPY, 2007, 2 (03) : 246 - 256